Supporting Breast Cancer Research

Dr. Maria Wynens, Au.D.Blog-post, News, Research

Dr. Maria Wynens, Au.D.
Latest posts by Dr. Maria Wynens, Au.D. (see all)

Supporting Breast Cancer Research

With Special Edition “Think Pink” Hearing Device, Dr. Wynens Supports Breast Cancer Research and Better Hearing

This October, Breast Cancer Awareness Month will celebrate 25 years of making a positive difference for women and their families in communities around the world.  Dr. Maria Wynens is proud to support this worthy cause in a way that will also make a positive difference for people with hearing loss in Atlanta.

Dr. Wynens is among a select group of U.S. hearing care practitioners to offer the new Oticon Agil “Think Pink,” a sleek, distinctively pink hearing device. During National Breast Cancer Awareness Month, Dr. Wynens will participate in the national “Pink with a Purpose” campaign to help raise funds for breast cancer research. Throughout October, leading hearing care manufacturer Oticon will donate a portion of proceeds from the sale of Agil “Think Pink” and all other Agil hearing devices to the National Breast Cancer Coalition.

New Agil is designed to enable people with hearing loss to minimize the cognitive energy expended in typical listening situations — without compromising sound quality and speech understanding. Agil preserves natural speech cues so less energy is needed to translate and interpret the meaning of sounds.

Agil takes much of the hard work out of organizing, selecting and following sounds so that people with hearing loss can stay engaged and active in everyday activities. “With the addition of the Streamer, a sleek companion device that resembles an MP3 player, Agil connects wirelessly to TVs, cell and landline phones and other popular communication devices.”

Special edition Agil “Think Pink” is available in tiny mini behind-the-ear device that is almost invisible on the ear.  Dr. Wynens notes that the Agil family of hearing instruments can accommodate approximately 80 percent of hearing losses.